Feb 29, 2024 / 07:30PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst
Thanks, everyone, for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. We have Norman Schwartz and Andy last with us from Bio-Rad. Guys, thanks for being here.
Questions and Answers:
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior AnalystMaybe Norman, we can start off. You guys just finished -- just finished the year, kind of gave your initial '24 guidance range. Maybe just talk about, I guess, the general backdrop, what you guys are seeing as we head into '24 here and just general expectations for trends as we work our way through the year, and we can certainly dive into some specifics.
Norman D. Schwartz - Bio-Rad Laboratories, Inc. - Chairman, CEO, President & Principal Financial Officer
Yes. I think that, interestingly enough, we expected '23 to be a year of normalization. And I think we're looking at '24 now the year of normalization. We had that kind of the meltdown of
Trustpilot
